Want to see JP:7707 full AI Analyst Report?

Precision System Science Co.,Ltd (7707) Price & Analysis

1 Followers

7707 Stock Chart & Stats

¥186.00

¥1.00(0.41%)

At close: Jan 08 4:00 PM EST

¥186.00

¥1.00(0.41%)

Day’s Range― - ―

52-Week Range¥175.00 - ¥299.00

Previous CloseN/A

Volume1.89M

Average Volume (3M)159.67K

Market Cap

¥5.73B

Enterprise Value¥5.24B

Total Cash (Recent Filing)¥942.70M

Total Debt (Recent Filing)¥885.01M

Price to Earnings (P/E)41.8

Beta1.52

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)4.93

Shares Outstanding27,666,900

10 Day Avg. Volume171,040

30 Day Avg. Volume159,673

Financial Highlights & Ratios

PEG Ratio0.28

Price to Book (P/B)1.46

Price to Sales (P/S)1.17

P/FCF Ratio127.16

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Focused Lab-automation BusinessA clear specialization in laboratory automation ties the company to a durable structural trend: labs and research entities increasingly pursue automation to improve throughput and consistency. This niche positioning supports repeatable systems sales, aftermarket service opportunities, and long-term demand for workflow solutions.

Recent Top-line RecoveryReported revenue growth of ~11.3% signals a recovery phase after prior declines, indicating demand traction for its automation systems. Sustained revenue expansion can enable scale economies, provide resources for product development, and create a foundation for margin improvement without sole reliance on external financing.

Moderate Leverage / Reasonable Equity BaseA relatively stable debt-to-equity profile and reasonable equity ratio imply moderate leverage, preserving financial flexibility. This capital structure supports the ability to fund capital expenditures for equipment, invest in product enhancements, and endure cycles without immediate refinancing stress, aiding multi-month resilience.

Bears Say

Persistent UnprofitabilityThe company's income statement shows persistent negative net, EBIT, and EBITDA margins, reflecting ongoing unprofitability. Sustained losses limit internal funding for R&D and commercialization, hinder retained-earnings accumulation, and make achieving durable operating leverage and investor-return metrics more challenging over the medium term.

Volatile Cash ConversionOperating cash flow has been inconsistent with only recent improvements and free-cash-flow conversion challenges. Weak and volatile cash conversion reduces funding autonomy, increases reliance on external capital for growth capex or working capital, and elevates execution risk when investing to scale systems or expand service offerings.

Negative ROE & Margin VariabilityNegative ROE over recent years combined with inconsistent gross margins points to operational inefficiencies and poor returns on invested capital. If sustained, this undermines long-term shareholder value creation, weakens competitive positioning versus more efficient peers, and complicates capital allocation decisions.

7707 FAQ

What was Precision System Science Co.,Ltd’s price range in the past 12 months?

Precision System Science Co.,Ltd lowest stock price was ¥175.00 and its highest was ¥299.00 in the past 12 months.

What is Precision System Science Co.,Ltd’s market cap?

Precision System Science Co.,Ltd’s market cap is ¥5.73B.

When is Precision System Science Co.,Ltd’s upcoming earnings report date?

Precision System Science Co.,Ltd’s upcoming earnings report date is Aug 14, 2026 which is in 21 days.

How were Precision System Science Co.,Ltd’s earnings last quarter?

Precision System Science Co.,Ltd released its earnings results on May 15, 2026. The company reported ¥5.1 earnings per share for the quarter, beating the consensus estimate of N/A by ¥5.1.

Is Precision System Science Co.,Ltd overvalued?

According to Wall Street analysts Precision System Science Co.,Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Precision System Science Co.,Ltd pay dividends?

Precision System Science Co.,Ltd pays a Notavailable dividend of ¥5 which represents an annual dividend yield of N/A. See more information on Precision System Science Co.,Ltd dividends here

What is Precision System Science Co.,Ltd’s EPS estimate?

Precision System Science Co.,Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Precision System Science Co.,Ltd have?

Precision System Science Co.,Ltd has 27,666,900 shares outstanding.

What happened to Precision System Science Co.,Ltd’s price movement after its last earnings report?

Precision System Science Co.,Ltd reported an EPS of ¥5.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.292%.

Which hedge fund is a major shareholder of Precision System Science Co.,Ltd?

Currently, no hedge funds are holding shares in JP:7707

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Precision System Science Co.,Ltd

Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese domestic market and international clientele. The company's product line includes essential plastic consumables designed for its automated systems, a range of reagents, and sophisticated automated systems for nucleic acid extraction and veterinary biochemical analysis. PSS also offers geneLEAD, a specialized instrument crucial for molecular diagnostics. Furthermore, the firm is actively engaged in the research, development, and practical application within the in vitro diagnostics sector, particularly focusing on genetic and protein testing. Established in 1985, Precision System Science Co., Ltd. is headquartered in Matsudo, Japan.